Table 1.
National cross-sectional survey—characteristics of the participants
| Multiple choice answers | Responses | |
|---|---|---|
| Under 30 years | 5.71% | 6 |
| Between 30 and 60 years | 71.43% | 75 |
| Over 60 years | 22.86% | 24 |
| Female | 89.52% | 94 |
| Male | 10.48% | 11 |
| Smokers no | 90.48% | 95 |
| Smokers yes | 9.52% | 10 |
| Breast cancers | 66.28% | 57 |
| Pelvic cancers | 11.63% | 10 |
| Abdominal cancers | 4.65% | 4 |
| Leukaemia | 3.49% | 3 |
| Prostate cancers | 1.16% | 1 |
| Kidney cancers | 0.00% | 0 |
| Lung cancers | 1.16% | 1 |
| Other cancers | 11.63% | 10 |
| Surgery | 75.58% | 65 |
| Chemotherapy | 66.28% | 57 |
| Radiotherapy | 70.93% | 61 |
| Hormone therapy | 46.51% | 40 |
| Radiofrequency | 1.16% | 1 |
| Other treatments | 17.44% | 15 |
| Relapse no | 89.53% | 77 |
| Relapse yes | 10.47% | 9 |
| Negative COVID-19 Pcr | 96.12% | 99 |
| Positive COVID-19 Pcr-Asymptomatic | 2.91% | 3 |
| Positive COVID-19 Pcr with hospitalisation | 0.97% | 1 |
| Positive COVID-19 Pcr with intensive care admission | 0.00% | 0 |